Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Addus HomeCare Corporation(ADUS)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for ADUS
10/23/2026: ADUS (2-star) has a low Upturn Star Rating. Not recommended to BUY.
Addus HomeCare Corporation is a major provider of home-based care, including personal care, hospice, and home health services, with a strong focus on Medicaid-funded programs. The company's primary strength lies in its ability to scale through targeted acquisitions and maintain operational stability in a fragmented market. Its growth strategy centers on cross-selling higher-margin clinical services to its existing patient base. However, the business faces significant risks from labor cost inflation, state-level reimbursement pressure, and M&A execution hurdles. This stock may suit growth-oriented investors who are comfortable with sector-specific regulatory risks, keeping in mind that the company does not currently pay a dividend.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | The company offers a consistent growth narrative through M&A and demographic tailwinds. |
| Momentum investor | Mixed fit | Momentum varies based on market sentiment toward healthcare services and acquisition news flow. |
| Value investor | Mixed fit | Valuation often reflects the premium paid for reliable, recurring revenue growth in home care. |
| Dividend investor | Weak fit | The company does not pay a dividend, prioritizing capital allocation for business expansion. |
| Low-risk investor | Mixed fit | While services are essential, exposure to state Medicaid funding and labor risks introduces operational volatility. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium | The stock can be sensitive to healthcare policy news and market-wide sentiment on growth stocks. |
| Valuation risk | Medium | Market pricing of home health providers can fluctuate based on perceived M&A multiples. |
| Competition risk (Fragmented provider landscape) | Medium | The ease of entry for small providers keeps localized market share competition high. |
| Business quality | Medium | The company has established a stable service model, though it remains sensitive to external funding sources. |
| Dividend income | Low / none | Addus does not provide income through dividends. |
| Execution risk | Medium | Success depends heavily on the ability to integrate acquisitions without disrupting clinical outcomes. |
Price Behavior
Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.
Smooth
The stock has moved along a generally orderly path with only modest fluctuations.
Analysis of Past Performance
Type Stock | Historic Profit 6.39% | Avg. Invested days 36 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Advisory Rating  | Upturn Advisory Performance  3.0 | Stock Returns Performance  2.0 |
| Profits based on simulation | Last Close 10/23/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 2.27B USD | Price to earnings Ratio 21.33 | 1Y Target Price 134.08 |
Price to earnings Ratio 21.33 | 1Y Target Price 134.08 | ||
Volume (30-day avg) 204.0K shares | Beta 0.83 | 52 Weeks Range 87.95 - 124.44 | Updated Date 10/23/2026 |
52 Weeks Range 87.95 - 124.44 | Updated Date 10/23/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 5.71 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Personal Care | Non-medical assistance for daily living, billed largely to state Medicaid programs. | This is the company's core recurring revenue source, providing essential support to seniors. |
| Hospice and Home Health | Clinical nursing and palliative care, billed to Medicare and private payers. | These higher-margin services represent the company's primary growth engine. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Valuation
Trailing PE 21.33 | Forward PE 16.89 | Enterprise Value 2.26B | Price to Sales(TTM) 1.54 |
Enterprise Value 2.26B | Price to Sales(TTM) 1.54 | ||
Enterprise Value to Revenue 1.77 | Enterprise Value to EBITDA 16.67 | Shares Outstanding 18.67M | Shares Floating 17.75M |
Shares Outstanding 18.67M | Shares Floating 17.75M | ||
Percent Insiders 2.81 | Percent Institutions 107.81 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.